Dentsply Sirona Inc is a global leader in the dental industry, specializing in the manufacturing and distribution of a wide range of dental products and technologies. The company provides innovative solutions for dental professionals, including equipment, instruments, and materials used in various dental procedures, such as restorative, preventive, and orthodontic care. Dentsply Sirona focuses on improving patient outcomes through advancements in dental technology, offering products that enhance treatment efficiency and effectiveness. By catering to dental professionals worldwide, the company plays a pivotal role in enhancing oral health and clinical practice standards.
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, notifies investors that the deadline to move for lead plaintiff in a securities class action lawsuit against Dentsply Sirona, Inc. (NASDAQ: XRAY) (“Dentsply” or the “Company”) and certain other defendants (collectively, “Defendants”) is January 27, 2025.
NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against DENTSPLY SIRONA Inc. (“Dentsply” or the “Company”) (NASDAQ:XRAY) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Dentsply securities between December 1, 2022 and November 6 2024, both dates inclusive (the “Class Period”). Investors have until January 27, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, notifies investors that the deadline to move for lead plaintiff in a securities class action lawsuit against Dentsply Sirona, Inc. (NASDAQ: XRAY) (“Dentsply” or the “Company”) and certain other defendants (collectively, “Defendants”) is January 27, 2025.
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) and certain of its officers.
SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased Dentsply Sirona Inc. (NASDAQ: XRAY) common stock between December 1, 2022 and November 6, 2024. Dentsply manufactures professional dental products, for example, CAD/CAM computer-aided design and manufacturing systems, imaging equipment, motorized dental handpieces, consumables (e.g., files, sealers, needles), implants, prosthetics, and orthodontics, such as clear aligners.
NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of DENTSPLY SIRONA Inc. (“Dentsply” or the “Company”) (NASDAQ: XRAY) between December 1, 2022 and November 6, 2024, inclusive.
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between December 1, 2022 and November 6, 2024. Dentsply describes itself as a company that “manufactures professional dental products.”
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Dentsply To Contact Him Directly To Discuss Their Options
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) (“DENTSPLY”).
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) for potential breaches of fiduciary duty on the part of its directors and management.
